RETATRUTIDE: Research Triple-Pathway Incretin Analog (GLP-1 / GIP / Glucagon) 1× GLP3-RTA (40mg)
$220.00
RETATRUTIDE
GLP3-RTA (LY-3437943) – 40 MG
GLP3-RTA (LY-3437943) is a research-use-only peptide analog designed to interact with GLP-1, GIP, and glucagon receptor pathways. This compound is under investigation in metabolic research settings focused on obesity, type 2 diabetes, and related metabolic disorders.
Note: Not for human or veterinary use. For in-vitro research only.